Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28727593 | 0.98 | CYP2C19 (0.48) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL28938744 | 0.98 | CYP2C19 (0.48) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL28729111 | 0.96 | CYP2C19 (0.47) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL21359975 | 0.89 | SMN1; SMN2 (0.44) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL27934590 | 0.85 | ALDH1A1 (0.49) | KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL6722251 | 0.85 | CYP2C19 (0.48) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL8494650 | 0.85 | SMN1; SMN2 (0.47) | MAPTKMT2ACYP1A2HDAC3HDAC1 | |
| SCHEMBL28682985 | 0.85 | CYP2C19 (0.48) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL9424924 | 0.84 | MAPT (0.51) | CYP2C19MAPTKMT2ACYP1A2HDAC3 | |
| SCHEMBL2030597 | 0.83 | MAPT (0.59) | CYP2C19HIF1AMAPTKMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115290793-B | Method for judging storage time of semi-fermented type fermented bean curd | 上海应用技术大学 | 2025-03-21 | — | — | CN | claimed |
| CN-115290793-A | Method for judging storage time of semi-fermented strong-smelling preserved bean curd | 上海应用技术大学 | 2022-11-04 | — | — | CN | claimed |
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| CN-109809962-A | A kind of new synthetic method of 2- (4- bromomethyl) phenylpropionic acid | 盘锦格林凯默科技有限公司 | 2019-05-28 | — | — | CN | claimed |
| CN-108290871-A | Isoindolinone inhibitors of MDM2-P53 interaction with anti-cancer activity | 阿斯泰克斯治疗有限公司 | 2018-07-17 | — | — | CN | claimed |
| EP-2600736-B1 | FOOD PRODUCT COMPRISING A BASE INGREDIENT COMPRISING CEREAL SEEDS | MISTER BIO FOOD S R L (IT) | 2018-07-04 | — | — | EP | claimed |
| EP-2033635-A1 | Short-chain fatty acid derivatives for treating pruritus | Asan Laboratories Company (Cayman) Limited (CN) | 2009-03-11 | — | — | EP | claimed |
| CN-101380317-A | Pharmaceutical composition for relieving pruritus | CAYMAN ISLAND SHANGANSHENG DEV (CN) | 2009-03-11 | — | — | CN | claimed |
| US-20080107646-A1 | Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier | Sunny Pharmtech Inc. (TW) | 2008-05-08 | — | — | US | claimed |
| CN-101166730-A | Cinnoline compounds and their use as liver X receptor modilators | WYETH CORP (US) | 2008-04-23 | — | — | CN | claimed |
| CN-1914173-A | Quinolines useful in treating cardiovascular disease | WYETH CORP (US) | 2007-02-14 | — | — | CN | claimed |
| US-6403646-B1 | ADMINISTERING PHENYLBUTYRIC ACID OR DERIVATIVES TO TREAT LIVER DISEASE AND EMPHYSEMA CAUSED BY PROTEASE INHIBITOR TYPE Z MUTATION; STIMULATES SECRETION WITHOUT INCREASING SYNTHESIS OF PROTEIN | PERLMUTTER DAVID H (US) | 2002-06-11 | — | — | US | claimed |
| JP-60081108-A | — | — | None | — | — | JP | disclosed |
| CN-119923418-A | Methacrylic acid-containing composition, method for producing methacrylic acid ester, polymerizable composition, and method for producing methacrylic acid polymer | 三菱化学株式会社 | 2025-05-02 | — | — | CN | disclosed |
| US-20220411410-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED | 2022-12-29 | — | — | US | disclosed |
| CN-115290793-A | Method for judging storage time of semi-fermented strong-smelling preserved bean curd | 上海应用技术大学 | 2022-11-04 | — | — | CN | disclosed |
| US-3933898-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| JP-S0681105-A | — | — | 0001-01-01 | — | — | JP | disclosed |
| JP-S0681108-A | — | — | 0001-01-01 | — | — | JP | disclosed |
| JP-S0681103-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411410-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | CFTR, ABCB1, ABCC2 | CYP2C19 1915/4885HIF1A 1715/4885MAPT 4484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.